Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index; 12 of the 51 sources its claims cite were checked for support.
Abstract
C3 deficiency protects against hippocampal neurodegeneration and cognitive decline in aged APP/PS1 mice despite abundant Aβ plaques.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
10 Valid · 1 Not valid · 23 Not checked · 77 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Consistent with our previous results (5), C3 KO mice had significantly more synaptic puncta than WT mice.”
§ Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice > Results > Partial protection against age-related hippocampal synaptic degeneration in APP/PS1;C3 KO mice
What the sources say
- Partly supportedcites [5] Shi Q, Colodner KJ, Matousek SB, Merry K, Hong S, Kenison JE, Frost JL, Le KX, Li S, Dodart JC, Caldarone BJ, Stevens B, Lemere CA, Complement C3-Deficient Mice Fail to Display Age-Related Hippocampal Decline. J Neurosci 35, 13029– 13042 (2015). 26400934 PMC6605437 sourceExperimental — accuracy not yet measured
Our copy does report significantly higher synaptic puncta density in C3 KO vs WT mice, but only with age and region bounds the citing sentence drops: at P30 there were no genotype differences, at 4 months only presynaptic Vglut2-IR puncta differed (p = 0.0347) with no difference in Homer1 or colocalization, and the full increase (Vglut2 p = 0.002, Homer1 p < 0.0001, colocalization p = 0.0109) appears at 16 months in HC CA3-SR, with similar effects in DG-SM and V1 but explicitly no differences in CA1 (Results, 'Complement-deficient mice do not display age-related synapse loss'; Fig. 2 legend, 'C3 deficiency in neurodegeneration'). The unqualified statement 'C3 KO mice had significantly more synaptic puncta than WT mice' therefore overstates the source by omitting the aged-timepoint and region-specific qualifiers. The supporting evidence for the direction of the effect (and corroborating Golgi spine-density and Western blot synaptic-marker increases at 16 months) is present in the same sections. (LLM, conf=0.70)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Complement activation is elevated in human AD brain, especially in the presence of fibrillar amyloid plaques containing clusters of reactive microglia (8, 9, 11, 12)”
§ Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice > Discussion
What the sources say
- Supportedcites [8] Stoltzner SE, Grenfell TJ, Mori C, Wisniewski KE, Wisniewski TM, Selkoe DJ, Lemere CA, Temporal accrual of complement proteins in amyloid plaques in Down’s syndrome with Alzheimer’s disease. Am J Pathol 156, 489– 499 (2000). 10666378 PMC1850044 source
The paper states that classical complement activation has been observed in AD brain and that compacted amyloid plaques in AD are often associated with activated microglia and complement proteins. Its Discussion further links abundant complement proteins in compacted plaques with activated microglia in AD-type lesions. The indexed passages provide section labels but no page numbers. (LLM, conf=0.86)
- Not checked yetcites [9] Eikelenboom P, Hack CE, Kamphorst W, Rozemuller JM, Distribution pattern and functional state of complement proteins and alpha 1-antichymotrypsin in cerebral beta/A4 deposits in Alzheimer’s disease. Res Immunol 143, 617– 620 (1992). 1455052 source
- Not checked yetcites [11] Veerhuis R, Histological and direct evidence for the role of complement in the neuroinflammation of AD. Curr Alzheimer Res 8, 34– 58 (2011). 21143154 source
- Not checked yetcites [12] Tenner AJ, Complement in Alzheimer’s disease: opportunities for modulating protective and pathogenic events. Neurobiol Aging 22, 849– 861 (2001). 11754992 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“We recently demonstrated that C3-deficiency spared age-dependent synaptic and neuronal loss in a region-specific manner, and protected against cognitive impairment in normal aging of C57BL/6 mice (5).”
§ Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice > Introduction
What the sources say
- Supportedcites [5] Shi Q, Colodner KJ, Matousek SB, Merry K, Hong S, Kenison JE, Frost JL, Le KX, Li S, Dodart JC, Caldarone BJ, Stevens B, Lemere CA, Complement C3-Deficient Mice Fail to Display Age-Related Hippocampal Decline. J Neurosci 35, 13029– 13042 (2015). 26400934 PMC6605437 source
The section 'Complement-deficient mice do not display age-related HC neuron loss' (p. ~ Results) states that age-dependent, region-specific synapse and neuron loss seen in WT C57BL/6J mice (CA3-SR, DG-SM reduced; CA1 spared) was rescued in aged male C3 KO mice, who had more synaptic puncta, higher SYP density and synaptic protein levels, higher LTP and more CA3 neurons. The section 'Complement C3-deficient mice do not display age-dependent behavioral deficits' states that C3 deficiency significantly protected mice against age-related cognitive decline, and the Summary ('C3 deficiency in neurodegeneration') reiterates that these age-related effects were spared in C3 KO mice. All elements of the citing sentence — C3-deficiency, sparing of age-dependent synaptic and neuronal loss in a region-specific manner, protection against cognitive impairment, and normal aging of C57BL/6 mice — are carried by our copy. (LLM, conf=0.93)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Previously, we reported an age-dependent loss of CA3 neurons in 16 month-old C57BL/6 mice (5).”
§ Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice > Discussion
What the sources say
- Supportedcites [5] Shi Q, Colodner KJ, Matousek SB, Merry K, Hong S, Kenison JE, Frost JL, Le KX, Li S, Dodart JC, Caldarone BJ, Stevens B, Lemere CA, Complement C3-Deficient Mice Fail to Display Age-Related Hippocampal Decline. J Neurosci 35, 13029– 13042 (2015). 26400934 PMC6605437 source
The Results section, “Complement-deficient mice do not display age-related HC neuron loss,” reports significantly fewer CA3 neurons in 16-month-old wild-type mice than at P30. The paper identifies the wild-type mice as C57BL/6J. The 16-month versus 4-month comparison was not significant, so the demonstrated loss is relative to P30. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“16-month-old APP/PS1;C3 KO mice performed significantly better on a learning and memory task than APP/PS1 mice, despite having more cerebral Aβ plaques.”
- Also stated in: § Sparing of cognitive decline in plaque-burdened aged APP/PS1;C3 KO mice · plain
“Reversal learning in APP/PS1;C3 KO mice was similar to that of WT mice and C3 KO mice, and was significantly better than that of APP/PS1 mice on Days 4 and 5”
§ Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Sparing of cognitive decline in plaque-burdened aged APP/PS1;C3 KO mice · plain
48 more claims
Create a free account to see all 111 claims and to verify the 39 references still open.
- Probably not a substantial claim. 35
- It may state two separate claims as one. 35
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Actually, inflammation even happens earlier than protein aggregation.”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“increasing evidence demonstrate that immune signaling may not just be a consequence of protein aggregation in the brain, but that it actually causes the buildup of aggregates at the earliest stages of the disease process.15–17”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, IFN-γ-induced C3 expression in an amyloidogenic mouse model reduced plaque load but resulted in increased loss of synapses and cognitive dysfunction [152, 284].”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [284]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These findings align with previous reports suggesting that plaque morphology, rather than total amyloid burden, may be a key factor in neurotoxicity and disease progression and suggest that this could be an important role for plaque‐associated PLCγ2 expressing microglia (Casali et al. 2020; Shi et al. 2017; Yuan et al. 2016).”
From Alzheimer's Protection by PLCγ2 Compacts Plaques, Redistributes Microglia, and Protects Synapses in App NL ‐G‐F Mice (2026) · cites this paper as Shi et al. 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, recent data indicate that microglia and astrocytes coordinate their functions in many ways, both in the healthy and diseased brain [14–21].”
From Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates (2021) · cites this paper as [17]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice > Discussion
“Recently, Hong et al. reported similar Aβ oligomer-induced, complement-mediated and microglia-dependent synaptic loss in young, pre-plaque AD mice that was rescued by the genetic deletion of C1q or C3, or by treatment with a C1qa blocking antibody (8).”
§ Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice > References
“10. Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q, Rosenthal A, Barres BA, Lemere CA, Selkoe DJ, Stevens B, Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352, 712– 716 (2016). 27033548 PMC5094372”
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519
Self-citationRetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synapse loss is an early and important change in AD brain (41), and hippocampal synapse loss is observed in APP/PS1 mice (28, 29).”
BackgroundTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationComplement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
Self-citationThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313
Self-citationMicroglia promote learning-dependent synapse formation through brain-derived neurotrophic factor
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., Hempstead, B. L., Littman, D. R., & Gan, W.-B. (2013) · Cell · doi:10.1016/j.cell.2013.11.030 · Cited by 2,599 · cited 1×
“Furthermore, mice deficient in BDNF in microglia have deficits in learning andhippocampal synapse formation, indicating thatmicroglial BDNF signaling plays an important role in hippocampal function (60).”
BackgroundSynapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Cited by
Items 301–400 of 603
Scott‐Hewitt, N., Huang, Y., & Stevens, B. (2023) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15010 · Cited by 24
Self-citationXu, J., Liu, J., Li, Q., Li, G., Zhang, G., Mi, Y., Zhao, T., Mu, D., Wang, D., Zeng, K., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155011 · Cited by 28
Nogueras‐Ortiz, C. J., Mahairaki, V., Delgado‐Peraza, F., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.14.041863 · Cited by 23
Lau, S., Fu, A. K. Y., & Ip, N. Y. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15933 · Cited by 24
The Diverse Roles of Reactive Astrocytes in the Pathogenesis of Amyotrophic Lateral Sclerosis
Yang, K., Liu, Y., & Zhang, M. (2024) · Brain Sciences · doi:10.3390/brainsci14020158 · Cited by 33
Zelek, W. M., Bevan, R. J., Nimmo, J., Dewilde, M., Strooper, B. D., & Morgan, B. P. (2024) · Brain · doi:10.1093/brain/awae278 · Cited by 27
von Saucken, V. E., Jay, T. R., & Landreth, G. E. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105072 · Cited by 23
Complement C3 deficiency ameliorates aging related changes in the kidney
Wu, X., Lin, L., Cui, J., Chen, Y., Yang, L., & Wan, J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118370 · Cited by 22
Immunity impacts cognitive deficits across neurological disorders
Shaw, B. C., Anders, V., Tinkey, R. A., Habean, M. L., Brock, O. D., Frostino, B. J., & Williams, J. L. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15999 · Cited by 44
O’Leary, T. P., Hussin, A. T., Gunn, R. K., & Brown, R. E. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.05.021 · Cited by 19
Tzioras, M., Daniels, M. J. D., Davies, C., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/795930 · Cited by 20
Teipel, S. J., Dyrba, M., Ballarini, T., Brosseron, F., Bruno, D., Buerger, K., Cosma, N.-C., Dechent, P., Dobisch, L., Düzel, E., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215196 · Cited by 20
“[37] Shi Q, Chowdhury S, Ma R, Le KX, Hong S, Caldarone BJ, Stevens B, Lemere CA (2017) Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice.”
Schartz, N. D., Aroor, A., Li, Y., Pinzón-Hoyos, N., & Brewster, A. L. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1265944 · Cited by 18
Advances in Genetic and Molecular Understanding of Alzheimer’s Disease
Ibáñez, L., Cruchaga, C., & Fernández, M. V. (2021) · Genes · doi:10.3390/genes12081247 · Cited by 22
Sleep Disturbance and Alzheimer’s Disease: The Glial Connection
Sunkaria, A., & Bhardwaj, S. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03578-0 · Cited by 21
Zuo, Z., Qi, F., Xing, Z., Yuan, L., Yang, Y., He, Z., Zhou, L., & Yao, Z. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.01.001 · Cited by 19
Tajmim, A., Cuevas-Ocampo, A. K., Siddique, A. B., Qusa, M. H., King, J. A., Abdelwahed, K. S., Sonju, J. J., & Sayed, K. A. E. (2021) · Nutrients · doi:10.3390/nu13051702 · Cited by 22
The Dual Nature of Microglia in Alzheimer’s Disease: A Microglia-Neuron Crosstalk Perspective
Xie, Z., Meng, J., Wu, Z., Nakanishi, H., Hayashi, Y., Kong, W., Lan, F., Narengaowa, Yang, Q., Qing, H., et al. (2023) · The Neuroscientist · doi:10.1177/10738584211070273 · Cited by 19
Dhankhar, J., Agrawal, N., & Shrivastava, A. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577302 · Cited by 18
Complement therapeutics in neurodegenerative diseases
Zelek, W. M., & Tenner, A. J. (2025) · Immunobiology · doi:10.1016/j.imbio.2025.153089 · Cited by 21
Effects of exercise on neuroinflammation in age-related neurodegenerative disorders
Su, Y., & Su, Z. (2025) · European journal of medical research · doi:10.1186/s40001-025-03165-3 · Cited by 26
Jie, X., Ran, L., Zeng, X., He, W., Xu, Y., Cao, K., Dong, Y., Qi, X., Yu, W., Xiao, Y. C., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17006 · Cited by 20
Thomas, R., Connolly, K. J., Brekk, O. R., Hinrich, A. J., Hastings, M. L., Isacson, O., & Hallett, P. J. (2023) · Scientific Reports · doi:10.1038/s41598-023-41240-z · Cited by 18
Schroeder, M. K., Liu, B., Hinshaw, R. G., Park, M., Wang, S., Dubey, S., Liu, G. G., Shi, Q., Holton, P., Reiser, V., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413305 · Cited by 21
Self-citationZhao, Z., Xiong, S., Gao, J., Zhang, Y., Guo, E., & Huang, Y. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05939-5 · Cited by 25
Guan, P.-P., Ge, T.-Q., & Wang, P. (2023) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-023-10076-9 · Cited by 21
Astrocytes Excessively Engulf Synapses in a Mouse Model of Alzheimer’s Disease
Li, L., Lü, S., Zhu, J., Yu, X., Hou, S., Huang, Y., Niu, X., Du, X., & Liu, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021160 · Cited by 18
Astrocyte-secreted C3 signaling impairs neuronal development and cognition in autoimmune diseases
Zhu, F., He, P., Jiang, W., Afridi, S. K., Xu, H., AlAhmad, M., Huang, Y. A., Qiu, W., Wang, G., & Tang, C. (2024) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2024.102654 · Cited by 18
O’Connor, M. G., Shentu, Y., Wang, G., Hu, W., Xu, Z., Wang, X., Liu, R., & Man, H. (2020) · iScience · doi:10.1016/j.isci.2020.101465 · Cited by 19
Microglia, synaptic dynamics and forgetting
Wang, C., Wang, L., & Gu, Y. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.06.005 · Cited by 20
Beneficial versus Detrimental Effects of Complement–Microglial Interactions in Alzheimer’s Disease
Ayyubova, G., & Fazal, N. (2024) · Brain Sciences · doi:10.3390/brainsci14050434 · Cited by 24
Progress in the mechanisms of pain associated with neurodegenerative diseases
Tian, Z., Zhang, Q., Wang, L., Li, M., Li, T., Wang, Y., Cao, Z., Jiang, X., & Luo, P. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102579 · Cited by 18
Gao, R., Gao, Y., Su, W., & Wang, R. (2025) · Aging and Disease · doi:10.14336/ad.2024.1629 · Cited by 34
Astrocyte Mitochondria in White-Matter Injury
Nguyen, H., Zerimech, S., & Baltan, S. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03239-8 · Cited by 20
Extracellular vesicles: A new communication paradigm of complement in neurological diseases
Gu, X., Chen, A., Su, Y., You, M., Guo, H., Tan, S., He, Q., & Hu, B. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110667 · Cited by 18
Complement C3 Affects Rac1 Activity in the Developing Brain
Gorelik, A., Sapir, T., Ben‐Reuven, L., & Reiner, O. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00150 · Cited by 18
Chen, Y., Zhao, Z., Fen, L., Wang, L., Lin, Z., & Yue, W. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.647246 · Cited by 17
Zhu, X., Ma, T., Liu, L., & Dai, W.-Z. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.332160 · Cited by 16
Li, Y., Li, Y., Fang, X., Chen, D., Yu, W., & Zhu, Z. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1365448 · Cited by 20
Hu, W., Chen, M., Lin, Y., Zhang, H., Sun, L., Shao, W., Ye, Y., Cheng, Y., Zhou, S., Hu, P., et al. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01378-x · Cited by 20
Impaired Synaptic Plasticity Mechanisms in Alzheimer’s Disease
Ebrahimi, R., Golzari, Z., Heidari‐Foroozan, M., Khosravi, A., Sharghi, S. G., Saleh, M., Salarvandian, S., & Esmaeilpour, K. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01712-9 · Cited by 23
Du, M., Jiang, T., He, S., Cheng, B., Zhang, X., Li, L., Yang, L., Gao, W., Li, Y., & Wang, Q. (2023) · Cells · doi:10.3390/cells12010197 · Cited by 18
Baassiri, M. G. E., Rahal, S. S., Fulton, W. B., Sodhi, C. P., Hackam, D. J., & Nasr, I. W. (2023) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000003887 · Cited by 20
The microglial P2Y6 receptor as a therapeutic target for neurodegenerative diseases
Dundee, J. M., & Brown, G. C. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00438-5 · Cited by 16
Singh, P. K., Kawasaki, M., Berk-Rauch, H., Nishida, G., Yamasaki, T., Foley, M. A., Norris, E. H., Strickland, S., Aso, K., & Ahn, H. J. (2018) · Biochemistry · doi:10.1021/acs.biochem.7b01214 · Cited by 15
Bai, Q., Shao, E., Ma, D., Jiao, B., Scheetz, S. D., Hartnett, K. A., Ильин, В. Н., Aizenman, E., Kofler, J., & Burton, E. A. (2024) · Nature Communications · doi:10.1038/s41467-024-52173-0 · Cited by 21
Zou, W., Kou, L., Wang, Y., Jin, Z., Xiong, N., Wang, T., & Xia, Y. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01005-z · Cited by 17
Microglia in Brain Aging and Age-Related Diseases: Friends or Foes?
Ishikawa, K., Fujikawa, R., Okita, K., Kimura, F., Watanabe, T., Katsurabayashi, S., & Iwasaki, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311494 · Cited by 19
Is the Exposome Involved in Brain Disorders through the Serotoninergic System?
Sarrouilhe, D., Defamie, N., & Mesnil, M. (2021) · Biomedicines · doi:10.3390/biomedicines9101351 · Cited by 19
C3aR in astrocytes mediates post-thoracotomy pain by inducing A1 astrocytes in male rats
Zhu, A., Cui, H., Su, W., Liu, C., Yu, X., & Huang, Y. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166672 · Cited by 18
Byrne, R. A. J., Torvell, M., Daskoulidou, N., Fathalla, D., Kokkali, E., Carpanini, S. M., & Morgan, B. P. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02419-5 · Cited by 13
Fighting fire with fire: The immune system might be key in our fight against Alzheimer’s disease
Dujardin, P., Vandenbroucke, R. E., & Hoecke, L. V. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.01.004 · Cited by 15
Nand, S., Chaturvedi, V. K., Singh, S. P., & Singh, M. P. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00219 · Cited by 14
The Role of the Complement System in Synaptic Pruning after Stroke
Liu, H., Jiang, M., Chen, Z., Li, C., Yin, X., Zhang, X., & Wu, M. (2024) · Aging and disease · doi:10.14336/ad.2024.0373 · Cited by 14
“In addition, blocking complement and downstream iC3b/CR3 signal transduction before Aβ accumulation can inhibit synaptic loss and prevent cognitive decline [121].”
Montoliu‐Gaya, L., Bian, S., Dammer, E. B., Alcolea, D. A., Sauer, M., Martá-Ariza, M., Ashton, N. J., Belbin, O., Fuchs, J., Watson, C. M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61054-z · Cited by 20
Pillat, M. M., Ayupe, A. C., Juvenal, G. D. A., Meinerz, C., Glaser, T., Pellegrina, D. V. D. S., Paiva, D. D. S., Mello, C. F., Longo, B. M., Reis, E. M. R., et al. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10542-0 · Cited by 12
Byrne, R. A. J., Nimmo, J., Torvell, M., Carpanini, S. M., Daskoulidou, N., Hughes, T. R., Noble, L. V., Veteleanu, A., Watkins, L. M., Zelek, W. M., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.03.026 · Cited by 16
Park, J. W., Kim, J. E., Choi, Y. J., Kang, M. J., Choi, H. J., Bae, S. J., Hong, J. T., Lee, H., & Hwang, D. Y. (2020) · The FASEB Journal · doi:10.1096/fj.202000376r · Cited by 13
Lockhart, E. F., Dolcetti, F. J. C., Herrera, M. L., Pennini, J., Villar, M. F. Z., Salinas, G., Portiansky, E. L., Spittau, B., Lacunza, E., Hereñú, C. B., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02791-w · Cited by 15
Alzheimer’s disease: Pathophysiology and dental pulp stem cells therapeutic prospects
Xiong, W., Liu, Y., Zhou, H., Jing, S., He, Y., & Ye, Q. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.999024 · Cited by 17
Aghaizu, N. D., Jolly, S., Samra, S. K., Kalmár, B., Craessaerts, K., Greensmith, L., Salinas, P. C., Strooper, B. D., & Whiting, P. J. (2023) · eNeuro · doi:10.1523/eneuro.0306-22.2022 · Cited by 15
Advances in proteomic phenotyping of microglia in neurodegeneration
Sunna, S. N., Bowen, C. A., Ramelow, C. C., Santiago, J. V., Kumar, P., & Rangaraju, S. (2023) · PROTEOMICS · doi:10.1002/pmic.202200183 · Cited by 13
Var, S. R., Strell, P., Johnson, S. T., Roman, A., Vasilakos, Z., & Low, W. C. (2023) · Cell Transplantation · doi:10.1177/09636897231171001 · Cited by 15
Microglial CD2AP deficiency exerts protection in an Alzheimer’s disease model of amyloidosis
Zhang, L., Huang, L., Zhou, Y., Meng, J., Zhang, L., Zhou, Y., Zheng, N., Guo, T., Zhao, S., Wang, Z., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00789-7 · Cited by 13
Immunosenescence of brain accelerates Alzheimer’s disease progression
Chen, H.-Y., Zhao, Y. G., & Xie, Y. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0021 · Cited by 12
MicroRNA-mediated regulation of reactive astrocytes in central nervous system diseases
Fan, Y., Huang, H., Shao, J., & Huang, W. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1061343 · Cited by 14
Lantz, M. J., Roberts, A. M., Delgado, D. D., & Nichols, R. A. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02807-9 · Cited by 13
Gene interactions analysis of brain spatial transcriptome for Alzheimer's disease
Wang, S., Greenbaum, J., Qiu, C., Swerdlow, R. H., Haeri, M., Gong, Y., Shen, H., Xiao, H., & Deng, H. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101337 · Cited by 14
Benetik, S. F., Knez, D., Obreza, A., Košak, U., & Gobec, S. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108748 · Cited by 15
Li, L.-J., Liang, S., Sun, X., Zhu, J., Niu, X.-Y., Du, X.-Y., Huang, Y., & Liu, R. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03333-6 · Cited by 15
Huang, C., Wei, Z., Zheng, N., Yan, J., Zhang, J., Ye, X., & Zhao, W. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14618 · Cited by 18
Refining the interactions between microglia and astrocytes in Alzheimer’s disease pathology
Chen, J., Xu, S., Wang, L., Liu, X., Liu, G., Tan, Q., Li, W., Zhang, S., & Du, Y. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.033 · Cited by 17
Glial phagocytosis for synapse and toxic proteins in neurodegenerative diseases
Choi, Y., & Chung, W. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00870-9 · Cited by 16
Yuan, T., Orock, A. M., & Meerveld, B. G. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00307.2021 · Cited by 16
Wu, M., Chen, K., Jiang, M., Xie, F., Cao, X., Chen, L., Chen, Z., & Yin, X. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1103278 · Cited by 12
Ramírez, S., Koerich, S., Astudillo, N., Gregorio, N. D., Al‐Lahham, R., Allison, T., Rocha, N. P., Wang, F., & Soto, C. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242317087 · Cited by 14
TREM2: Keeping Microglia Fit during Good Times and Bad
Hong, S. Y., & Stevens, B. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.09.010 · Cited by 13
Self-citationMackey-Alfonso, S. E., & Barrientos, R. M. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70911 · Cited by 15
Radiotherapy for non-cancer diseases: benefits and long-term risks
Thariat, J., Little, M. P., Zablotska, L. B., Samson, P. P., O’Banion, M. K., Leuraud, K., Bergom, C. R., Girault, G., Azimzadeh, O., Bouffler, S. D., et al. (2024) · International Journal of Radiation Biology · doi:10.1080/09553002.2023.2295966 · Cited by 15
Jin, D., Zhang, M., Shi, L., & Liu, H. (2024) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyae038 · Cited by 15
Rodríguez-López, A., Esteban, D., Domínguez‐Romero, A. N., & Gevorkian, G. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115189 · Cited by 9
Hollis, H. C., Sharma, A., Sheehan, P. W., Maggi, L. B., Weber, J. D., Hammarlund, J. A., Bennett, D. A., Menon, V., Musiek, E. S., & Anafi, R. C. (2025) · Neuron · doi:10.1016/j.neuron.2025.07.010 · Cited by 21
Brain transcriptome analysis of a CLN2 mouse model as a function of disease progression
Domowicz, M. S., Chan, W., Vázquez, P. N. C., Gonzalez, T., & Schwartz, N. B. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02302-z · Cited by 12
Gazzar, W. B. E., Farag, A. A., Samir, M., Bayoumi, H., Youssef, H. S., Marei, Y. M., Mohamed, S. K., Marei, A. M., Abdelfatah, R. M., Mahmoud, M. M., et al. (2024) · BioFactors · doi:10.1002/biof.2107 · Cited by 14
Daskoulidou, N., Shaw, B., Zelek, W. M., & Morgan, B. P. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70458 · Cited by 18
Hippocampal complement C3 might contribute to cognitive impairment induced by anesthesia and surgery
Ji, M., Qiu, L.-L., Mao, M., Zhang, L., & Yang, J. (2020) · Neuroreport · doi:10.1097/wnr.0000000000001422 · Cited by 10
Microglia: Rheostats of space radiation effects in the CNS microenvironment
Kerry O'Banion, M. (2022) · Life Sciences in Space Research · doi:10.1016/j.lssr.2022.08.002 · Cited by 10
Maksour, S., & Ooi, L. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15885 · Cited by 13
Headmasters: Microglial regulation of learning and memory in health and disease
Weinhard, L., d’Errico, P., & Tay, T. L. (2018) · AIMS molecular science · doi:10.3934/molsci.2018.1.63 · Cited by 12
Wickstead, E. S., Irving, M. A., Getting, S. J., & McArthur, S. (2021) · FEBS Journal · doi:10.1111/febs.15861 · Cited by 11
Hesse, R., Hurtado, M. L., Jackson, R. J., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/631556 · Cited by 10
Zhou, R., Jia, X., Li, Z., Huang, S., Feng, W., & Zhu, X. (2024) · Scientific Reports · doi:10.1038/s41598-024-68054-x · Cited by 11
Vecchiarelli, H. A., Lopes, L. T., Paolicelli, R. C., Stevens, B., Wake, H., & Tremblay, M. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_11 · Cited by 10
Self-citationDaskoulidou, N., Carpanini, S. M., Zelek, W. M., & Morgan, B. P. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_524 · Cited by 12
Liu, T., Rong, Z., Li, J., Wu, H., & Wei, J. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101846 · Cited by 14
Liu, L.-Z., Fan, S., Gao, J., Li, W., & Xian, X. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110683 · Cited by 9
Hasantari, I., Nicolas, N., Alzieu, P., Leval, L., Shalabi, A., Grolleau, S., & Dinet, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042272 · Cited by 12
Presymptomatic change in microRNAs modulates Tau pathology
Sharma, S., Khadimallah, I., Corya, A. W., Ali, Y., Rao, X., Liu, Y., & Lu, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-27527-6 · Cited by 10
2017 Yearbook of Neurorestoratology
Huang, H., Skaper, S. D., Mao, G., Saberi, H., Feng, S., Jeon, S. R., Chen, L., & Dimitrijevic, M. R. (2018) · Journal of Neurorestoratology · doi:10.26599/jnr.2018.9040001 · Cited by 9
Schartz, N. D., Li, Y., Sommer, A. L., & Brewster, A. L. (2024) · Epilepsia Open · doi:10.1002/epi4.13030 · Cited by 7
Metadata
- Authors
- Shi, Q., Chowdhury, S., Ma, R., Le, K. X., Hong, S., Caldarone, B. J., Stevens, B., & Lemere, C. A.
- Affiliations
- Brigham and Women's Hospital (US)
- Boston Children's Hospital (US)
- Corresponding author
- Lemere, Cynthia A.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2017-05-31
- Volume
- 9
- Issue
- 392
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC6936623
- OpenAlex
- W2618794795
- Semantic Scholar
- 9b3f6a14369dd65bfc394e92ccb26bd20b83ccd0
- Cited by
- 593
- References
- 70
- Citations by year
- 2026: 47 · 2025: 72 · 2024: 75 · 2023: 71 · 2022: 66 · 2021: 88 · 2020: 64 · 2019: 50 · 2018: 43 · 2017: 17
- FWCI
- 35.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (award298479, R21 AG044713)
- BrightFocus Foundation (award298478, A2016425F)
- Fidelity Biosciences (award298481, (F-PRIME), award298470, F-PRIME)
- Edward R and Anne G Lefler (award298482, Fellowship)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Keywords
- complement C3, complement system, neurodegeneration, Alzheimer's disease, APP/PS1 mice, amyloid plaques, microglia, synaptic loss, neuronal loss, aging, glial response
- MeSH terms
- Aging, Animals, Astrocytes, Complement C3, Gliosis, Hippocampus, Mice, Inbred C57BL, Nerve Degeneration, Solubility, Synapses, Cytokines, Amyloid beta-Protein Precursor, Mice, Knockout, Presenilin-1, Plaque, Amyloid, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.